Pharma-Bio Serv (PBSV) Net Income towards Common Stockholders Growth (1y) (2011 - 2026)
Pharma-Bio Serv (PBSV) Net Income towards Common Stockholders Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 26.11 Bn | 18.79 Bn | 662.02 Mn | 14.35% |
| 2 | BrightSpring Health Services | 12.95 Bn | 12.07 Bn | 482.22 Mn | 275.50% |
| 3 | Healthequity | 7.46 Bn | 7.19 Bn | 256.31 Mn | 28.75% |
| 4 | Hinge Health | 5.15 Bn | 4.83 Bn | 154.23 Mn | -71.96% |
| 5 | Doximity | 3.75 Bn | 3.00 Bn | 125.97 Mn | -69.40% |
| 6 | 10x Genomics | 3.69 Bn | 3.15 Bn | 106.18 Mn | 60.80% |
| 7 | Waystar Holding | 3.61 Bn | 3.45 Bn | 268.04 Mn | 48.00% |
| 8 | Privia Health | 2.90 Bn | 2.54 Bn | 595.71 Mn | -38.64% |
| 9 | Omnicell | 1.72 Bn | 1.54 Bn | 140.36 Mn | 262.39% |
| 10 | Pharma-Bio Serv | - | - | 722,374.00 | 284.96% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 284.96% |
| Oct 31, 2025 | -100.63% |
| Jul 31, 2025 | 30.85% |
| Apr 30, 2025 | 144.60% |
| Jan 31, 2025 | 103.15% |
| Oct 31, 2024 | 134.17% |
| Jul 31, 2024 | -158.76% |
| Apr 30, 2024 | -152.84% |
| Jan 31, 2024 | -163.48% |
| Oct 31, 2023 | -127.19% |
| Jul 31, 2023 | 82.70% |
| Apr 30, 2023 | 68.59% |
| Jan 31, 2023 | 39.70% |
| Oct 31, 2022 | 103.56% |
| Jul 31, 2022 | -87.34% |
| Apr 30, 2022 | -0.10% |
| Jan 31, 2022 | 13.88% |
| Oct 31, 2021 | -3,475.66% |
| Jul 31, 2021 | 228.72% |
| Apr 30, 2021 | -65.05% |